首页 > 期刊杂志 > 正文

Role of Tetrasomy for the Diagnosis of Urothelial Carcinoma Using UroVysion Fluorescent In Situ Hybridization.

利用UroVysion荧光原位杂交技术检测四体性在尿路上皮癌诊断中的应用价值

Zhou AG,Liu Y,Cyr MS,Garver J,Woda BA,Cosar EF,Hutchinson LM

Abstract

-UroVysion fluorescent in situ hybridization (FISH) is routinely used to detect urothelial carcinoma (UC). A positive threshold is defined as chromosome polysomy in 4 or more cells, which also includes tetrasomy, a natural product of cell division.
-To evaluate tetrasomy for UC detection and explore the relation to the surgical diagnosis or patient history.
-The FISH was performed on 1532 urine samples from patients with cytology results and 4 or more years of follow-up. We created separate polysomy and tetrasomy categories and constructed receiver operating curves to determine appropriate thresholds using biopsy (n = 194) as the gold standard. Standard FISH and a novel assay integrating cytomorphology and FISH (Target-FISH) were compared. Matching tissue biopsies of urine samples with 10 or more tetrasomy cells were analyzed.
-No significant threshold was found for tetrasomy cells. Exclusion of tetrasomy from the polysomy category changed the threshold from 8.5 to 4.5 cells, increased specificity (59.2% to 78.9%), but reduced sensitivity (78.9% to 65.9%). In Target-FISH, the same approach yielded a specificity of 93.7% and sensitivity of 65.2%. Similarly, specificity improved significantly for low- and high-grade UC, but sensitivity decreased for low-grade UC. No evidence of UC was observed in 95% (52 of 55) of the patients referred for screening who had 10 or more tetrasomy cells by FISH. Matching biopsies for urines containing 10 or more tetrasomy cells showed few or no tetrasomy cells.
-Tetrasomy is a nonspecific finding frequently encountered in urine FISH and should be excluded from the polysomy classification. Target-FISH is an optimal approach, offering the ability to detect rare tetrasomy tumors.

摘要

UroVysion荧光原位杂交技术常用来检测尿路上皮癌(UC),其阳性阈值是指四个及四个以上细胞检出染色体多体性,这也包括细胞分裂的自然产物——染色体的四体性。

-评价染色体四体性对UC的诊断价值并探究其与外科诊断或病人病史之间的关系。 

-对有细胞学结果的1532例患者尿液样本进行FISH检测,并随访4年以上。我们建立了将多体性和四体性分的分类方法,并构建了可作为金标准的接收器工作曲线,依此确定行活检(n=194)的恰当阈值。对标准的FISH和将细胞形态检测及FISHTarget-FISH)结合在一起的技术进行比较。对有10个或以上细胞发现四体性的尿液标本进行组织活检。 

-对于四体性细胞来说,没有发现显著的阈值,当多体性分类中去除四体性时,其阈值从8.5个细胞变为4.5个,特异性由59.2%升高为78.9%,但敏感性由78.9%降低为65.9%。利用Target-FISH技术进行检测时,相同情况下特异性达93.7%,敏感性为65.2% 。与此类似,低级别或高级别UC的特异性显著升高,但低级别UC敏感性降低。FISH检测发现10个及以上细胞四体性的患者中,95%52/55)的通常规筛查未见UC证据。尿液标本中含10个或以上四体性细胞相对应的活检标本,没有发现或只有少数四体性细胞。

-利用FISH检测尿液四体性细胞是一种非特异性的结果,应该将其从多体性分类中去除。Target-FISH技术是一种理想的检测方法,可检测罕见的四体性肿瘤。



full text

我要评论

0条评论